Assessment of the Effects on Barrier Impairment, Clinical Features and Bacterial Colonization of Topical Formulations in Patients With Atopic Eczema; a Phase IIa, Single-center, Randomized, Observer-blind Study
CompletedNCT00863005
Moberg Pharma ABAtopic Dermatitis
Updated: 2009-11-06